Paul B. Manning - 25 Jun 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Paul B. Manning
Issuer symbol
CADL
Transactions as of
25 Jun 2025
Net transactions value
+$4,999,996
Form type
4
Filing time
26 Jun 2025, 08:30:10 UTC
Previous filing
20 Jun 2025
Next filing
02 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Paul B. Manning filed Form 4 for Candel Therapeutics, Inc. (CADL) on 26 Jun 2025."

Quick Takeaways

  • This page summarizes Paul B. Manning's Form 4 filing for Candel Therapeutics, Inc. (CADL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 26 Jun 2025, 08:30.

What Changed

  • Previous filing in this sequence was filed on 20 Jun 2025.
  • Current net transaction value: +$4,999,996.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Manning Paul B Director C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM /s/ Charles Schoch, as Attorney-In-Fact for Paul B. Manning 26 Jun 2025 0001494695

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Award $4,999,996 +1,070,663 +94% $4.67 2,213,069 25 Jun 2025 By Paul B. Manning Revocable Trust F1, F2
holding CADL Common Stock 1,303,752 25 Jun 2025 By BKB Growth Investments, LLC F3
holding CADL Common Stock 1,681,000 25 Jun 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.
F2 The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3 The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F4 Includes shares held jointly with spouse.

Sponsored